- Home
- NNVC vs ACST Comparison
NNVC vs ACST Comparison
Compare NNVC & ACST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNVC
- ACST
- Stock Information
- Founded
- NNVC 2005
- ACST 2002
- Country
- NNVC United States
- ACST United States
- Employees
- NNVC N/A
- ACST N/A
- Industry
- NNVC Biotechnology: Pharmaceutical Preparations
- ACST Pharmaceuticals and Biotechnology
- Sector
- NNVC Health Care
- ACST Health Care
- Exchange
- NNVC Nasdaq
- ACST Nasdaq
- Market Cap
- NNVC 17.7M
- ACST 27.2M
- IPO Year
- NNVC N/A
- ACST N/A
- Fundamental
- Price
- NNVC $1.50
- ACST $3.28
- Analyst Decision
- NNVC Strong Buy
- ACST Strong Buy
- Analyst Count
- NNVC 1
- ACST 2
- Target Price
- NNVC $6.50
- ACST $10.00
- AVG Volume (30 Days)
- NNVC 186.7K
- ACST 23.2K
- Earning Date
- NNVC 11-12-2024
- ACST 11-11-2024
- Dividend Yield
- NNVC N/A
- ACST N/A
- EPS Growth
- NNVC N/A
- ACST N/A
- EPS
- NNVC N/A
- ACST N/A
- Revenue
- NNVC N/A
- ACST N/A
- Revenue This Year
- NNVC N/A
- ACST N/A
- Revenue Next Year
- NNVC N/A
- ACST N/A
- P/E Ratio
- NNVC N/A
- ACST N/A
- Revenue Growth
- NNVC N/A
- ACST N/A
- 52 Week Low
- NNVC $1.00
- ACST $1.98
- 52 Week High
- NNVC $3.59
- ACST $3.59
- Technical
- Relative Strength Index (RSI)
- NNVC 48.18
- ACST 60.89
- Support Level
- NNVC $1.35
- ACST $3.20
- Resistance Level
- NNVC $1.54
- ACST $3.44
- Average True Range (ATR)
- NNVC 0.10
- ACST 0.17
- MACD
- NNVC 0.02
- ACST 0.01
- Stochastic Oscillator
- NNVC 61.11
- ACST 70.08
About NNVC NanoViricides Inc.
Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.
About ACST Acasti Pharma Inc.
Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.